baber/WOPTO huggingface dataset:
Patent CA-2600667-A1 (CA)
Inventor: COSTA FULVIO
IPC: C03C1/00
Filed: 2006-02-14
Abstract: Process for the production of monoliths of glass by means of the sol-gel process, comprising the following steps: a) dispersion in water of an oxide prepared by the pyrogenic route, b) hydrolysis of an alkoxide in aqueous solution to form a hydrolysate, c) mixing of the hydrolysate of the alkoxide with the oxide prepared by the pyrogenic route to form a colloidal sol, d) optional removal of coarse contents from the colloidal sol, e) gelling of the colloidal sol in a mould, f) replacement of the water contained in the resulting aerogel by an organic solvent, g) drying of the aerogel, h) heat treatment of the dried aerogel.
Patent CA-2600710-A1 (CA)
Inventor: PADBIDRI SUMANT
IPC: H04L29/06
Filed: 2006-02-24
Abstract: This invention is about a method, system, and program for processing requests transmitted using a first communication directed to an application that uses a second communication protocol. A server (2) receives a request from a client (4) over a network (6) in a first communication protocol. A determination is made at the Listener Port (16) as to whether the request includes an identifier of an application indicated in a data structure. A socket (20) is processed that enables communication between the application (10) identified by the identifier in response to determining that the identifier included in the request is indicated in the data structure. The socket (20) is provided to the application (10) associated with the requested resource to enable the application (10) to communicate with the client over the network using a second communication protocol .
Patent CA-2601312-A1 (CA)
Inventor: JENKINS SCOTT
IPC: A61K31/4745
Filed: 2006-03-16
Abstract: The invention is directed to an injectable nanoparticulate immunosuppressant composition for the formation of a subcutaneous or intramuscular depot. The invention is also directed to an injectable composition of nanoparticulate tacrolimus and/or sirolimus which eliminates the need to use polyoxyl 60 hydrogenated castor oil (HCO-60) and/or polysorbate 80 as a solubilizer. This invention further discloses a method of making an injectable nanoparticulate tacrolimus and/or sirolimus composition and is also directed to methods of treatment using the injectable nanoparticulate formulations comprising tacrolimus, sirolimus, or combination thereof for a subcutaneous or intramuscular depot for the prophylaxis of organ rejection and for the treatment of psoriasis or other immune diseases.
Patent CA-2601608-A1 (CA)
Title: Excavation apparatus and method
Inventor: RAJEWSKI ROBERT C
IPC: E02F3/88
Filed: 2007-09-07
Abstract: An excavation apparatus is provided having a loader, a tank, a vacuum pump and a vacuum hose. The loader has an engine and is mounted on either tracks or wheels, with the tank attached on the loader. Both of the vacuum pump and vacuum hose are in fluid connection with the tank. The vacuum hose draws excavated material into the tank, which draws its suction from the vacuum pump. The tank can easily dump its contents when full, and resume drawing in excavated material. The excavation apparatus can be easily transported to the job site using transport equipment the operation of which requires only basic licenses.  The loader may be a bobcat. This system may be used in tandem with a hydro excavation system.
Patent CA-2603949-A1 (CA)
Title: Evenement elite a5547-127 et procedes et trousses pour l'identification d'un tel evenement dans des echantillons biologiques
Inventor: DE BEUCKELEER MARC
IPC: C12Q1/68
Filed: 2006-04-04
Abstract: La présente invention a trait à des outils permettant l'identification rapide et sans équivoque d'événement élite A5547-127 dans des échantillons biologiques.
Patent CA-2606901-A1 (CA)
Title: Process for making aztreonam
Inventor: FIMOGNARI DOMENICO
IPC: C07D417/12
Filed: 2006-05-09
Abstract: A simplified process for the one-pot preparation of aztreonam, using azetidine and TAEM as starting materials, without the intermediary separation of t-butyl-aztreonam is provided.
Patent CA-2607523-A1 (CA)
Inventor: KEGERIS TED
IPC: E04B1/38
Filed: 2007-10-22
Abstract: A hinged magnetic assembly including at least two rotatable magnets and at least two arms used to secure the magnets and define a distance between the magnets, locking bolts to prevent rotation of the magnets and lock the magnets in a predetermined orientation, the hinged magnet assembly used to facilitate connecting construction elements together.
Patent CA-2607992-A1 (CA)
Title: Bicyclic compound, production and use thereof
Inventor: BABA MASANORI
IPC: A61K31/513
Filed: 2002-08-07
Abstract: The present invention provides a new cyclic compound having a CCR antagonist activity, especially a CCR5 antagonist activity, and the use thereof. The compound of the present invention is represented by the formula:     (see formula I) wherein, R1 is a 5- to 6-membered ring group which may be substituted; X1 is a bond or the like; ring A is a 5- to 6-membered ring group which may be substituted; ring B is a 8- to 10-membered ring group which may be substituted; X2 is a bivalent group of 1 to 4 atoms; Z1 is a bivalent cyclic ring group or the like; Z2 is a bond or the like;  and R2 is an amino group, nitrogen-containing heterocyclic group which may be substituted or the like, or a salt thereof.
Patent CA-2611658-A1 (CA)
Inventor: ENDO TAKAYUKI
IPC: B01J35/04
Filed: 2006-06-20
Abstract: A catalyst for purifying exhaust gases includes a substrate, and projections.  The substrate is provided with straight-flow gas-flow passages. The projections protrude from the straight-flow gas-flow passages in a height of 50 Êm or more, and include a precipitate, which is composed of at least one catalytic ingredient selected from the group consisting of alkali metals and alkaline-earth metals.
Patent CA-2611829-A1 (CA)
Inventor: WANG TIAN
IPC: G10L19/08
Filed: 2006-04-05
Abstract: L'invention concerne des techniques et des outils relatifs au codage et au décodage d'informations audio. Par exemple, des informations codées redondantes destinées à décoder une trame courante contiennent des informations d'historique de signaux associées uniquement à une partie d'une trame précédente. Dans un autre exemple, des informations redondantes codées destinées à décoder une unité codée contiennent des paramètres d'un étage de code à utiliser pour décoder l'unité courante codée uniquement si l'unité codée précédente n'est pas disponible. Dans encore un autre exemple, des unités audio codées contiennent chacune un champ indiquant si l'unité codée contient des informations codées principales représentant un segment d'un signal audio, et si l'unité codée contient des informations redondantes codées à utiliser dans le décodage des informations principales codées.
Patent CA-2614640-A1 (CA)
Title: Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
Inventor: WILDER RONALD
IPC: A61K39/395
Filed: 2006-07-11
Abstract: The present invention provides methods of treating, preventing or ameliorating the symptoms of T cell-mediated immunological diseases, particularly autoimmune diseases, through the use of anti-CD3 antibodies. In particular, the methods of the invention provide for administration of antibodies that specifically bind the epsilon subunit within the human CD3 complex. Such antibodies modulate the T cell receptor/alloantigen interaction and, thus, regulate the T cell mediated cytotoxicity associated with autoimmune disorders. Additionally, the invention provides for modification of the anti-CD3 antibodies such that they exhibit reduced or eliminated effector function and T cell activation as compared to non- modified anti-CD3 antibodies.
Patent CA-2616546-A1 (CA)
Title: Rotatable armrest
Inventor: CASSADAY TERRY
IPC: A47C7/54
Filed: 2007-12-28
Abstract: An armrest for a chair having a first member connected to the chair; a second member selectively rotatable relative the first member; means disposed between the first and second members for resisting the rotational movement between the first and second members.
Patent CA-2617140-A1 (CA)
Inventor: LEE HYUN AH
IPC: A61K47/44
Filed: 2006-06-26
Abstract: Disclosed herein are a pharmaceutical formulation with high stability and dissolution, and a method for preparing the pharmaceutical formulation. The pharmaceutical formulation comprises a pharmacologically active substance, a solvent, a solubilizer, a surfactant, an antioxidant, and an adsorbent.  According to the pharmaceutical formulation and the method, the pharmacologically active substance is mixed with the solvent, the solubilizer agent and the surfactant for improving the solubility of the pharmacologically active substance to obtain an amorphous liquid or semi-solid state, the antioxidant is melted together with the mixture to solve poor chemical stability of the pharmacologically active substance in an amorphous or liquid state, and the adsorbent is strongly adsorbed to the molten mixture so as to be transformed into a powder form so that the resulting molecules are reconstituted into very tiny crystal forms within the adsorbent to ensure chemical stability.
Patent CA-2618023-A1 (CA)
Inventor: RILEY YUSUN KIM
IPC: H04L47/80
Filed: 2005-12-20
Abstract: A method of creating a network-initiated secondary packet data service instance includes sending a content request for application data from a mobile station to an application function through an access network. The method further includes sending a request for a secondary packet data service instance from the application function to a policy function, and evaluating the request for a secondary packet data service instance and determining one or more operational attributes from the evaluation. The method also includes creating the secondary packet data service instance between the application function to the mobile station by arranging one or more network components as a function of the one or more operational attributes. The method further includes transmitting the application data from the application function to the mobile station via the secondary packet data service instance.
Patent CA-2619279-A1 (CA)
Title: Apparatus and method of delivering biomaterial to the heart
Inventor: MAVITY WILLIAM G
IPC: A61F2/00
Filed: 2006-07-27
Abstract: A biomaterial for treating or preventing congestive heart failure is injected into the intrapericardial space of a patient's heart to apply a mild compressive force on the heart. A volume of biomaterial is placed in the intrapericardial space by an injection needle or catheter, adjacent at least the left ventricle, so that the biomaterial applies a compressive force on the myocardium to relieve cardiac wall tension during at least a portion of the cardiac cycle.
Patent CA-2621057-A1 (CA)
Title: Ikk inhibitors for the treatment of endometriosis
Inventor: PALMER STEPHEN S
IPC: A61P15/00
Filed: 2006-08-28
Abstract: This invention relates to a method of treating and/or preventing endometriosis comprising administering an IKK inhibitor. The IKK inhibitor can also be administered combined with a hormonal suppressor. The invention further relates to the treatment of endometriosis-related infertility.
Patent CA-2623268-A1 (CA)
Inventor: WITTWER CARL THOMAS
IPC: G16B25/10
Filed: 2006-09-20
Abstract: A system and methods are provided for melting curve genotyping analysis of nucleic acids. Melting curves are generated by plotting fluorescence of a sample as a function of temperature. In one illustrative example, an exponential algorithm is employed to remove the background from generated melting curves and thereby perform comparative analysis to other melting curves. Additional illustrative examples provide for measuring the differences between two or more melting curves and clustering the genotypes of the provided sample nucleic acids.
Patent CA-2624573-A1 (CA)
Title: Method of obtaining vegetable proteins and/or peptides, proteins produced according to said method and/or peptides and use thereof
Inventor: LOTZ MARTIN
IPC: A23L33/00
Filed: 2008-03-07
Abstract: The present invention relates to a method of obtaining vegetable proteins and/or peptides, comprising the steps of: a) preparing a vegetable starting material containing proteins and/or peptides in an aqueous matrix; b) optionally eliminating solid components from said aqueous matrix and/or clarifying said aqueous matrix; c) isolating the proteins and/or peptides from the aqueous matrix by adsorption on at least one ion exchanger membrane made of a synthetic polymer; d) optionally rinsing the ion exchanger membrane in order to remove impurities; e) desorbing the proteins and/or peptides from the ion exchanger membrane with at least one eluent; f) isolating the proteins and/or peptides from the eluent; and g) optionally drying the isolated proteins and/or peptides; and a protein, peptide and/or mixtures thereof prepared in accordance with the method, and uses thereof.
Patent CA-2625387-A1 (CA)
Title: Radio transmitting apparatus, radio receiving apparatus, wireless communication method, and wireless communication system
Inventor: HOSHINO MASAYUKI
IPC: H04B7/04
Filed: 2006-11-02
Abstract: A radio transmitting apparatus, a radio receiving apparatus, a wireless communication method and a wireless communication system wherein even when a channel correlation is large, the channel capacity and the feedback amount can be improved. In ST401, a receiving apparatus (200) determines that the channel correlation value exceeds a predetermined threshold value. In ST402, a transmitting apparatus (100) is instructed to perform 4~2 MIMO transmission.  In ST403, the transmitting apparatus (100) determines a pair of antennas exhibiting the highest channel correlation. In ST406, the receiving apparatus (200) uses, based on the pair information, a channel matrix, which comprises channel estimation values, to calculate a delay shift amount. In ST407, the delay shift amount is fed back to the transmitting apparatus (100). In ST408, the transmitting apparatus (100) uses the pair information and delay shift amount to combine SDM and a cyclic sample delay diversity, thereby transmitting data.
Patent CA-2625722-A1 (CA)
Title: Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
Inventor: TENNAGELS NORBERT
IPC: C07D405/12
Filed: 2006-10-12
Abstract: The invention relates to carbamoylbenzotriazole derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.
Patent CA-2625802-A1 (CA)
Inventor: PALMER ROGER KEITH
IPC: A23B4/06
Filed: 2005-10-14
Abstract: Thermal regulation of perishable products is achieved using a container (2) having an elongate thermal member (14) which extends into a central region of the container. Thermal regulation is also achieved by selected direction of airflow about walls (4) of the container and providing the container with a rib (5) to facilitate air circulation between adjacent containers.
Patent CA-2626948-A1 (CA)
Title: Metal-to-metal non elastomeric seal stack
Inventor: GOMEZ ALFREDO
IPC: E21B34/14
Filed: 2006-10-23
Abstract: An improved seal assembly for use in sliding sleeve valves. The seal assembly incorporates a number of annular, chevron-shaped seal elements that are in a stacked configuration and preferably formed of a thermoplastic material to provide a fluid seal between the outer housing and the inner sleeve member of the sliding sleeve valve. In addition, the seal assembly preferably includes a pair of annular metallic seal members that have a C-ring cross-section (a "C-seal"). On opposite axial sides of each metallic C- seal are a C-seal support ring and an end adapter that are shaped and sized to assist the metallic C-seals to be axially compressed and uncompressed to resiliently seal against both the inner sleeve member and the outer housing.
Patent CA-2627272-A1 (CA)
Title: Modulation of 11beta-hydroxysteroid dehydrogenase 1 expression for the treatment of ocular diseases
Inventor: JIMENEZ ANTON ANA ISABEL
IPC: C12N15/113
Filed: 2006-10-25
Abstract: The invention relates to siNA compositions and methods for the treatment of eye conditions wherein the siNA compound capable of inhibiting the expression of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1).
Patent CA-2627673-A1 (CA)
Title: Kinase inhibitors
Inventor: POBANZ MARK ANDREW
IPC: A61K31/44
Filed: 2006-10-25
Abstract: The present invention provides kinase inhibitors of Formula (I). Wherein R1, R2, X and Z are as described herein, or a pharmaceutically acceptable salt thereof.
Patent CA-2629232-A1 (CA)
Title: Azaindole-2-carboxamide derivatives
Inventor: PLANCHER JEAN-MARC
IPC: C07D471/04
Filed: 2006-11-08
Abstract: The present invention relates to compounds of formula (I) wherein R1 to R5 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
Patent CA-2633913-A1 (CA)
Inventor: CHANG SOPHIE S
IPC: C12N15/11
Filed: 2008-07-04
Abstract: The present invention relates to isolated Solanum Bulbocastanum Bu1427 promoter sequences and uses thereof.
Patent CA-2637180-A1 (CA)
Inventor: GRAB LAWRENCE A
IPC: C10M173/02
Filed: 2007-02-02
Abstract: The passage of a container along a conveyor is lubricated by applying to the container or conveyor a lubricant composition comprising a water-miscible silicone material having a silicone emulsion wherein the silicone emulsion contains less than 500 ppm of a triethanolamine salts of alkyl benzene sulfonic acid compounds.
Patent CA-2642056-A1 (CA)
Inventor: YUSIBOV VIDADI
IPC: C07K14/025
Filed: 2007-02-13
Abstract: The present invention relates to the intersection of the fields of immunology and protein engineering, and particularly to antigens and vaccines useful in prevention of infection by human papilloma virus. Provided are recombinant protein antigens, compositions, and methods for the production and use of such antigens and vaccine compositions.
Patent CA-2643603-A1 (CA)
Inventor: YOUNG DAVID S F
IPC: A61P35/00
Filed: 2007-02-23
Abstract: The present invention relates to a method for producing cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, cytokines, interferons, target or reporter moieties and hematogenous cells.
Patent CA-2644255-A1 (CA)
Title: Chimeric kunitz domains and their use
Inventor: LENZ JUERGEN
IPC: A61K38/57
Filed: 2007-03-01
Abstract: The present invention relates to chimeras of human tissue factor inhibitor domain 1 with natural and non-natural Kunitz domains, and their preparation and use.
Patent CA-2646201-A1 (CA)
Inventor: ZASTROZYNSKI JURGEN
IPC: B23B27/14
Filed: 2007-04-20
Abstract: The invention relates to a cutting insert with a supporting surface (11) and a cutting surface at a distance therefrom and at least one flank (12) positioned by a positive clearance angle, which form a circumferential round or polygonal cutting edge, as well as at least one cutting edge point (13) at a maximum distance from a plane in which the supporting surface (11) is located and at least one cutting edge point (16, 17) at a minimum distance from said plane. According to the invention, the geometric location of each cutting edge point, but at least the cutting edge point (16, 17) at a minimum distance and points adjacent thereto is teh intersection point of a vertical envelope with a plane parallel to the supporting surface (11), wherein the vertical envelope is perpendicular to the supporting surface (11) and is formed by a plurality of parallel vertical lines (18, 19) that lie in the plane parallel to the support surface (11) in which the point (13) with maximum distance from the support surface plane lies and constitutes an ideal theoretical round or polygonal cutting edge curve.
Patent CA-2647396-A1 (CA)
Inventor: SUBRAMANIAM BALA
IPC: C07C47/00
Filed: 2007-03-16
Abstract: An improved hydroformylation process is provided, which comprises reacting a n olefin with CO and H2 in the presence of a hydroformylation catalyst in a liquid that has been volumetrically expanded with a compressed gas, such as supercritical carbon dioxide.
Patent CA-2648915-A1 (CA)
Inventor: BRANDT CAMERON S
IPC: C07K14/705
Filed: 2007-04-13
Abstract: La présente invention concerne un procédé de préparation d'une protéine tétramère comprenant la mise en culture d'une cellule-hôte transformée ou transfectée avec un vecteur d'expression encodant une protéine de fusion qui comporte un domaine de phosphoprotéine stimulée vasodilatatrice (VASP) et une protéine hétérologue. Dans l'un des modes de réalisation, la protéine hétérologue est une protéine membranaire, la portion qui en est inclus à la protéine de fusion est son domaine extracellulaire et la protéine de fusion qui en résulte est soluble. Le procédé peut être utilisé pour produire des protéines homotétramères et hétérotetramères. La présente invention concerne également des molécules d'ADN, des vecteurs d'expression et des cellules-hôtes utilisées par le procédé, ainsi que des protéines de fusion produites par le procédé.
Patent CA-2649690-A1 (CA)
Inventor: HANCE ROBERT L
IPC: C01B32/60
Filed: 2007-04-17
Abstract: A system for treating carbon-containing or silicon-containing end-of-life material includes a reactor (10) for simultaneously supporting oxidation of the waste material and conversion of CO2 within the reactor A metal oxide or metal is input to the reactor to convert the CO2 to a mineralized CO2 product. A cold trap (44) is provided for capturing exhaust gases from the reactor and returning condensate to the reactor, and a pump (50) maintains a desired vacuum or pressure within the reactor and the cold trap.
Patent CA-2651041-A1 (CA)
Inventor: WILLETT WILLIAM
IPC: A63H17/00
Filed: 2007-05-04
Abstract: A toy vehicle includes a central housing having first and second oppositely disposed sides. A first wheel is rotatably mounted on the first side of the housing and a second wheel is rotatably mounted on the second side of the housing. Each of the fxrst and second wheels has a central hub. Each hub has a center disposed along a common first axis of rotation. A plurality of vanes are attached to the hub and form the first and second wheels. An end of each vane distal to the hub forms a circumferential surface portion of one of the first and second wheels. Each vane is individually and separately manually angularly repositionable about a second vane axis extending transversely with respect to the first axis.
Patent CA-2651152-A1 (CA)
Title: 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
Inventor: REES DAVID CHARLES
IPC: A61P35/00
Filed: 2007-05-04
Abstract: The invention provides the compound of formula (I) 4-(2,6-dichloro-benzoylamino)-1H-pyrazole- 3-carboxylic acid (l-methanesulphonyl-piperidin-4-yl)-amide in a substantially crystalline form, therapeutic uses thereof and pharmaceutical compositions containing the crystalline compound. The invention also provides novel pharmaceutical formulations containing 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide and novel processes for preparing the compound.